Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs041180066
JPRN-jRCTs041180066
Completed
Phase 3

Clinical study about the intraocular operation using the adjuvant. - Clinical study about adjuvant.

Horiguchi Masayuki0 sites250 target enrollmentMarch 7, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Horiguchi Masayuki
Enrollment
250
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The triamcinolone acetonide-assisted phacoemulsification procedure is safe and useful for visualizing the posterior surface of the lens nucleus and facilitates removal of the lens nucleus by phacoemulsification.

Registry
who.int
Start Date
March 7, 2019
End Date
May 10, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Horiguchi Masayuki

Eligibility Criteria

Inclusion Criteria

  • •The patient who was enough explained and understand this study.
  • •The patient who agree this study by the free will and sign consent forms.
  • •The patient who was diagnosed adjuvant is appropriate.

Exclusion Criteria

  • •The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.Diabete Type 2CataractTriamcinolone AcetonideIntravitreal Injection
NCT05413330Damascus University73
Completed
Phase 3
Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular EdemaDiabetes MellitusMacular Edema
NCT00309192Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA292
Recruiting
Phase 4
Dropless Pars Plana Vitrectomy StudyRhegmatogenous Retinal Detachment
NCT05331664Massachusetts Eye and Ear Infirmary168
Completed
Phase 1
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersMacular DegenerationRetinal Vein Occlusion
NCT00071227National Eye Institute (NEI)16
Completed
Not Applicable
Perioperative intravitreal triamcinolone in phacoemulsification for concurrent clinically significant diabetic macular oedema
ISRCTN91792333Record Provided by the NHSTCT Register - 2007 Update - Department of Health56